Company / R&D per Share
Celcuity Inc. R&D per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.64
FY2024
5-year range
$0.75 / $2.64
FY2020-FY2024
Trend
+3.2%
vs FY2023
Sector context
#30 of 109
Health Care
What the data says
At $2.64, Celcuity Inc.'s r&d per share ranks #30 of 109 in the Health Care sector. R&D per Share has increased for 5 consecutive years, from $0.61 in FY2019 to $2.64 in FY2024.
Based on SEC 10-K filings.
2.64 in FY2024 with a 5-year CAGR of +33.9%.
Improved from $2.29 to $2.64 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- +33.9%
- 10-Year CAGR
- -
Sector benchmark
#30 of 109 in Health CareTop 28% of 109This company $2.64 Sector average $2.08
▼
+27.2% above sector average
Key checks
Key Insights
- Celcuity Inc.'s r&d per share has grown for 5 consecutive years.
- In FY2024, r&d per share increased 3.2% year-over-year.
- Ranks #30 out of 109 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.64 | +3.2% |
| FY2023 | $2.56 | +11.8% |
| FY2022 | $2.29 | +18.9% |
| FY2021 | $1.92 | +157.2% |
| FY2020 | $0.75 | +22.1% |
| FY2019 | $0.61 | -1.9% |
| FY2018 | $0.62 | +26.5% |
| FY2017 | $0.49 | +1.8% |
| FY2016 | $0.49 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026